Paolo Dellabona
San Raffaele Scientific Institute, ITALY, Italy
- This delegate is presenting an abstract at this event.
Paolo Dellabona graduated in Medicine and obtained a Ph.D. in Medical Genetics from the University of Torino. He is currently joint-head with Giulia Casorati of the Experimental Immunology Unit and head of the Division of Immunology, Transplantation and Infectious Diseases at the San Raffaele Scientific Institute in Milano, Italy. The main scientific interest of the Casorati/Dellabona lab concerns the understanding of the development and anti-tumor functions of CD1-restricted T and NKT lymphocytes.
Presentations this author is a contributor to:
CD1c Transgenic Mice as a Preclinical Platform for Evaluating CD1c-Restricted T Cell Immunity and Therapeutic Safety (#155)
12:30 PM
Michela Consonni
Lunch & Poster Session 2
CAR-iNKT cell adoptive immunotherapy for metastatic colon cancer (#156)
12:30 PM
Gloria Delfanti
Lunch & Poster Session 2
Design of cytokine engineered invariant Natural Killer T (iNKT) cells for adoptive immunotherapy of cancer (#62)
12:15 PM
Gloria Delfanti
Therapy of Cancer and Other Diseases 1
Adoptive immunotherapy of metastatic colon cancer with tumor redirected iNKT cells (#67)
2:45 PM
Paolo Dellabona
Therapy of Cancer and Other Diseases 2
CD1-MR1 2025